Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
May, 22 2026
Jan, 1 2026
Mar, 13 2026
Oct, 17 2025
Jun, 18 2026